← Back to home

FDA Approves GSK's Hibsago, a Hepatitis B Drug That May Let Some Patients Stop Long-Term Treatment

Fact checked by NewsPlainVerified by NewsPlain: confirmed by at least two named sources

Brief

The Food and Drug Administration on Tuesday, Oct. 20, approved GSK's Hibsago, or bepirovirsen, an injection given with…

Keep reading with NewsPlain Premium

Get the full brief, the full story, what's confirmed, what's still unclear, why it matters, and every source.

2 sources behind this story.

About this story

We haven’t published a correction to this story.

How NewsPlain works
← Back to home